Israel Englander’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-140,715
Closed -$591K 5874
2025
Q1
$591K Sell
140,715
-4,616
-3% -$28.8K ﹤0.01% 4705
2024
Q4
$981K Sell
145,331
-28,141
-16% -$130K ﹤0.01% 4217
2024
Q3
$567K Buy
173,472
+1,627
+0.9% +$8.97K ﹤0.01% 4725
2024
Q2
$1.08M Sell
171,845
-1,876
-1% -$14.3K ﹤0.01% 4056
2024
Q1
$1.27M Sell
173,721
-482
-0.3% -$4.02K ﹤0.01% 4106
2023
Q4
$1.62M Sell
174,203
-17,827
-9% -$164K ﹤0.01% 3782
2023
Q3
$1.86M Buy
192,030
+3,432
+2% +$53.6K ﹤0.01% 3618
2023
Q2
$4.11M Buy
188,598
+12,610
+7% +$335K ﹤0.01% 2842
2023
Q1
$4.95M Buy
175,988
+53,001
+43% +$1.59M ﹤0.01% 2611
2022
Q4
$2.77M Sell
122,987
-26,074
-17% -$595K ﹤0.01% 3289
2022
Q3
$3.56M Buy
+149,061
New +$4.81M ﹤0.01% 3213
2022
Q2
Sell
-1,291
Closed -$120K 6988
2022
Q1
$120K Sell
1,291
-39,641
-97% -$3.44M ﹤0.01% 6064
2021
Q4
$3.9M Buy
40,932
+31,130
+318% +$4.26M ﹤0.01% 3150
2021
Q3
$1.75M Buy
+9,802
New +$2.18M ﹤0.01% 4075
2021
Q2
Sell
-10,694
Closed -$2.88M 6541
2021
Q1
$2.88M Sell
10,694
-3,067
-22% -$934K ﹤0.01% 3179
2020
Q4
$3.18M Sell
13,761
-3,061
-18% -$822K ﹤0.01% 2857
2020
Q3
$4.22K Sell
16,822
-9,936
-37% -$2.35M 0.01% 1994
2020
Q2
$7.23M Buy
+26,758
New +$7.33M 0.01% 1458

Other funds holding BNR

Israel Englander's BNR Position: Q2 2025 in Review

Israel Englander sold out of Burning Rock Biotech (BNR) in Q2 2025, closing a stake of 140,715 shares — an estimated $591K sold.

Israel Englander first reported a position in BNR in Q2 2020 and held it in 18 quarters. The position peaked at $7.23M in Q2 2020. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2025.

  • Israel Englander reported no remaining Burning Rock Biotech position as of Q2 2025 after selling out during the quarter.
  • Israel Englander sold 140,715 Burning Rock Biotech shares in Q2 2025, an estimated $591K.
  • Israel Englander first reported a position in Burning Rock Biotech in Q2 2020 and held it in 18 quarters.
  • Israel Englander's Burning Rock Biotech position peaked at $7.23M in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.